Mechanism

GLP-1R; GCGR; FGF21R

Assets acting on this target.

Class
Fc-fusion tri-agonist
Notes
audit finding #1619 (minor); source: https://clinicaltrials.gov/api/v2/studies/NCT06555640

← all mechanisms